OBJECTIVE To study the bioactive phytochemicals in the leaves of A.ilicifolius against Hepatocellular carcinoma(HCC) through in silico,in vitro and in vivo studies.METHODS A.ilicifolius leaves were collected from Cudd...OBJECTIVE To study the bioactive phytochemicals in the leaves of A.ilicifolius against Hepatocellular carcinoma(HCC) through in silico,in vitro and in vivo studies.METHODS A.ilicifolius leaves were collected from Cuddalore District,Tamil Nadu,India.Authenticated by the Botanical Survey of India.The fresh leaves of A.ilicifolius were washed and shade dried at room temperature(28 ± 2)℃.The dried leaves were powdered by electrical blender.25 gms of A.ilicifolius leaf powder was used for methanol extraction in the Soxhlet apparatus.The Phytochemical compounds were analyzed by GC-MS and the structure was retrieved from PubChem.Totally,seven HCC target proteins were collected from literature,ligand and proteins were prepared for in silico molecular docking.HepG2 cell lines were used for in vitro(MTT assay).BALB/c mice were used for in vivo studies,the biochemical parameters and histopathological studies were carried out with standard procedure.RESULTS The phytochemical26.27-Di(nor)-cholest-5,7,23-trien-22-ol,3-methoxymethoxy exhibited maximum docking score against the HCC target protein C-Jun N-terminal kinase 1(JNK 1)(-6.839798).MTT assay revealed that the extract at a concentration of 200 μg·mL-1,caused 60% cell death in HepG2 cell lines.Further animal studies using to injecting HCC induced BALB/c mice,restoration of haematological parameters and cells to normal was observed after 15 days of oral administration of the extract.These findings suggest the possibility of using A.ilicifolius leaves in the treatment of HCC.CONCLUSION The in silico,in vitro and in vivo studies indicated that the A.ilicifolius leaves had anticancereous activity against Hepatocellular carcinoma.There can be a possibility of synergistic activity of phytochemicals together against HCC.展开更多
基金supported by Key Construction Program of International Cooperation Base in S＆T,Shaanxi Province,China(2015SD0018)
文摘OBJECTIVE To study the bioactive phytochemicals in the leaves of A.ilicifolius against Hepatocellular carcinoma(HCC) through in silico,in vitro and in vivo studies.METHODS A.ilicifolius leaves were collected from Cuddalore District,Tamil Nadu,India.Authenticated by the Botanical Survey of India.The fresh leaves of A.ilicifolius were washed and shade dried at room temperature(28 ± 2)℃.The dried leaves were powdered by electrical blender.25 gms of A.ilicifolius leaf powder was used for methanol extraction in the Soxhlet apparatus.The Phytochemical compounds were analyzed by GC-MS and the structure was retrieved from PubChem.Totally,seven HCC target proteins were collected from literature,ligand and proteins were prepared for in silico molecular docking.HepG2 cell lines were used for in vitro(MTT assay).BALB/c mice were used for in vivo studies,the biochemical parameters and histopathological studies were carried out with standard procedure.RESULTS The phytochemical26.27-Di(nor)-cholest-5,7,23-trien-22-ol,3-methoxymethoxy exhibited maximum docking score against the HCC target protein C-Jun N-terminal kinase 1(JNK 1)(-6.839798).MTT assay revealed that the extract at a concentration of 200 μg·mL-1,caused 60% cell death in HepG2 cell lines.Further animal studies using to injecting HCC induced BALB/c mice,restoration of haematological parameters and cells to normal was observed after 15 days of oral administration of the extract.These findings suggest the possibility of using A.ilicifolius leaves in the treatment of HCC.CONCLUSION The in silico,in vitro and in vivo studies indicated that the A.ilicifolius leaves had anticancereous activity against Hepatocellular carcinoma.There can be a possibility of synergistic activity of phytochemicals together against HCC.
